Furthermore, p53 disrupts mitochondrial quality control by sequestering Parkin (PARK2), a Parkinson’s disease-associated gene and potential tumor suppressor, in the cytosol, thereby inhibiting mitophagy and the clearance of damaged mitochondria [33]. This evidence concerns the gene PRKN and neoplasm.